Epigenomics AG 18.11.2015 18:30 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Voting Rights: Release of Voting Rights Notifications (§ 21 para. 1 German Securities Trading Act - 'WpHG') in Accordance with § 26 para. 1 WpHG with the Aim of an Europe-wide Distribution Issuer: Epigenomics AG - ISIN DE000A11QW50 - Geneststr. 5 10829 Berlin Germany Voting Rights Notifications: 1. On 17 November 2015, James E. Flynn, USA, notified Epigenomics AG of voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows: On 11 November 2015, as a consequence of the disposal of shares to which voting rights are attached, the share of James E. Flynn in the voting rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting rights (522,791 voting rights) in Epigenomics AG. All 2.89 per cent of the voting rights (522,791 voting rights) are attributed to James E. Flynn pursuant to sec. 22 para. 1 sent. 1 no. 1 WpHG and pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG in connection with sec. 22 para. 1 sent. 2 WpHG. 2. Furthermore, on 17 November 2015, J.E. Flynn Capital, LLC, Wilmington, Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows: On 11 November 2015, as a consequence of the disposal of shares to which voting rights are attached, the share of J.E. Flynn Capital, LLC in the voting rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting rights (522,791 voting rights) in Epigenomics AG. All 2.89 per cent of the voting rights (522,791 voting rights) are attributed to J.E. Flynn Capital, LLC pursuant to sec. 22 para. 1 sent. 1 no. 1 WpHG. 3. Furthermore, on 17 November 2015, Deerfield Mgmt, L.P., Wilmington, Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows: On 11 November 2015, as a consequence of the disposal of shares to which voting rights are attached, the share of Deerfield Mgmt, L.P. in the voting rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting rights (522,791 voting rights) in Epigenomics AG. All 2.89 per cent of the voting rights (522,791 voting rights) are attributed to Deerfield Mgmt, L.P. pursuant to sec. 22 para. 1 sent. 1 no. 1 WpHG. 4. Furthermore, on 17 November 2015, Deerfield Special Situations Fund, L.P., Wilmington, Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows: On 11 November 2015, as a consequence of the disposal of shares to which voting rights are attached, the share of Deerfield Special Situations Fund, L.P. in the voting rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting rights (522,791 voting rights) in Epigenomics AG. 5. Furthermore, on 17 November 2015, Flynn Management LLC, Wilmington, Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows: On 11 November 2015, as a consequence of the disposal of shares to which voting rights are attached, the share of Flynn Management LLC in the voting rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting rights (522,791 voting rights) in Epigenomics AG. All 2.89 per cent of the voting rights (522,791 voting rights) are attributed to Flynn Management LLC pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG in connection with sec. 22 para. 1 sent. 2 WpHG. 6. Furthermore, on 17 November 2015, Deerfield Management Company, L.P., Wilmington, Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows: On 11 November 2015, as a consequence of the disposal of shares to which voting rights are attached, the share of Deerfield Management Company, L.P. in the voting rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting rights (522,791 voting rights) in Epigenomics AG. All 2.89 per cent of the voting rights (522,791 voting rights) are attributed to Deerfield Management Company, L.P. pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG. Date of release: 18 November 2015 Epigenomics AG The Executive Board 18.11.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Epigenomics AG Geneststraße 5 10829 Berlin Germany Internet: www.epigenomics.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
18. November 2015 - 0:00 (CEST)